stubee2
Dr. Stuart Cantor is a graduate of the University of Maryland Pharmacy School. His pharmaceutical research expertise is in granulation processes, controlled-release solid dosage formulations, and NIR spectroscopy/Chemical imaging. His food science R&D expertise is with nutraceuticals, weight loss beverages, energy drinks, and tablets, and low-fat foods and Dr. Cantor has assisted global companies in their development and manufacturing scale-ups of both ingredients and finished products.
His background includes over two years of experience as the Senior R&D Manager at Capricorn Pharma, Inc., a start-up pharmaceutical company, where he learned about business planning/logistics, operations, and financing from the initial stages. Dr. Cantor has also gained expertise with global regulatory issues (small molecule and biologic drugs and consumer products) through work experience at ICON and Pfizer and has authored over 40 publications including book chapters on diverse food, nutraceutical, and pharmaceutical topics. Dr. Cantor previously developed the sugarless fiber chews for diabetics launched by Bristol Myers Squibb under the Choice DM® brand.
Read More »
His background includes over two years of experience as the Senior R&D Manager at Capricorn Pharma, Inc., a start-up pharmaceutical company, where he learned about business planning/logistics, operations, and financing from the initial stages. Dr. Cantor has also gained expertise with global regulatory issues (small molecule and biologic drugs and consumer products) through work experience at ICON and Pfizer and has authored over 40 publications including book chapters on diverse food, nutraceutical, and pharmaceutical topics. Dr. Cantor previously developed the sugarless fiber chews for diabetics launched by Bristol Myers Squibb under the Choice DM® brand.
...
- Content
- 0
- Fans
- 0
- Contributor since
- 9/3/2011
